FDA Accountability for Public Safety Act
Latest action · Apr 15, 2015 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 15, 2015
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
FDA Accountability for Public Safety Act
This bill requires the Commissioner of Food and Drugs to ensure that an advisory committee of the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA) evaluates each new drug application for an opioid (a drug with effects similar to opium, such as morphine) and issues a recommendation regarding approval of the drug. If the decision to approve the drug is inconsistent with the committee's recommendation, the Commissioner must make the final decision on approval.
If the committee recommends a drug not be approved but the Commissioner decides to approve the drug, the Commissioner must: (1) submit a report to Congress that includes the evidence regarding patient safety that supports the Commissioner's decision and a disclosure of any potential conflicts of interest of FDA officials involved in the decision to approve the drug; and (2) testify before Congress regarding the decision, upon request. Such a drug cannot be sold until the Commissioner has submitted the required report.Cosponsors 5
Members who signed on, in the order they did. Signatures ran from Apr 15, 2015 to Nov 19, 2015; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-LA | David Vitter | Original | Apr 15, 2015 |
| R-WV | Shelley Moore Capito | Original | Apr 15, 2015 |
| D-VA | Tim Kaine | Original | Apr 15, 2015 |
| D-MO | Claire McCaskill | Sep 9, 2015 | |
| I-ME | Angus S. King Jr. | Nov 19, 2015 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Apr 15, 2015 |
Actions 2
Everything that happened, newest first.
- Apr 15, 2015Introduced in Senate
- Apr 15, 2015Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S6179 | Joe Manchin III D-WV | Sep 28, 2016 |
| Senate | Debate and remarks S945–S952 | Joe Manchin III D-WV | Feb 23, 2016 |
| Senate | Debate and remarks S719 | Joe Manchin III D-WV | Feb 9, 2016 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R43416 | Energy Provisions in the 2014 Farm Bill (P.L. 113-79): Status and Funding Archived | Report | Jul 12, 2018 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.
- Short Titles as Introduced
- FDA Accountability for Public Safety Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
- Federal officials
- Food and Drug Administration (FDA)
- Government ethics and transparency, public corruption
- Health
- Marketing and advertising
- Prescription drugs
Text 1
Each version as it was printed, newest first.
- Apr 15, 2015Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.